These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 5998858)

  • 1. [Hypocholestermic agents in therapy].
    Grossi F; Palleschi M
    Clin Ter; 1966 Oct; 39(1):65-77. PubMed ID: 5998858
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapy of atherosclerosis: lipid regulation and direct anti-atherosclerotic effect].
    Internist (Berl); 1998 Oct; 39(10 Suppl Lipidregul):1-4. PubMed ID: 9810870
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of dyslipemias with the association of dx-thyroxine and choleretics].
    Martinelli M; Albini U; Villecco A
    Boll Soc Ital Cardiol; 1970; 15(6):539-43. PubMed ID: 5517650
    [No Abstract]   [Full Text] [Related]  

  • 4. [What is new? Therapy with lipid lowering agents].
    Internist (Berl); 1997 Nov; 38(11 Suppl Therapie):1-8. PubMed ID: 9403084
    [No Abstract]   [Full Text] [Related]  

  • 5. [Diphosphonate (disodium etidronate) lowers cholesterol and total lipid levels in the blood of humans].
    Caniggia A; Gennari C; Picchi M
    Boll Soc Ital Biol Sper; 1974 Sep; 50(17):1416-22. PubMed ID: 4218488
    [No Abstract]   [Full Text] [Related]  

  • 6. Atherosclerosis target of lipid-lowering therapy: is lower LDL cholesterol better?
    Jones PH
    Am J Manag Care; 2003 Aug; Suppl():1, 4-5. PubMed ID: 13678393
    [No Abstract]   [Full Text] [Related]  

  • 7. [Atherosclerosis and Regelan].
    Schwaar R
    Praxis; 1966 Aug; 55(31):875-80. PubMed ID: 5953569
    [No Abstract]   [Full Text] [Related]  

  • 8. [The drug therapy of hypercholesterolemia].
    Berthold HK; von Bergmann K
    Dtsch Med Wochenschr; 1996 May; 121(22):729-34. PubMed ID: 8646985
    [No Abstract]   [Full Text] [Related]  

  • 9. [Evaluation of the efficacy of statin therapy in dyslipidemic diseases such as combined hypercholesterolemia IIA and hyperlipidemia].
    Liguori E; Sarcinella R
    Minerva Cardioangiol; 1998 Sep; 46(9):317-8. PubMed ID: 10021861
    [No Abstract]   [Full Text] [Related]  

  • 10. [Arteriosclerosis: how plaque heals].
    Neumaier J
    MMW Fortschr Med; 2002 Dec; 144(51-52):9. PubMed ID: 12596673
    [No Abstract]   [Full Text] [Related]  

  • 11. Some clinical potentials of chlorophenoxyisobutyrate (clofibrate) therapy (hyperlipidemia--angina pectoris--blood sludging-diabetic neuropathy).
    Duncan GG; Elliott FA; Duncan TG; Schatanoff J
    Metabolism; 1968 May; 17(5):457-73. PubMed ID: 5648211
    [No Abstract]   [Full Text] [Related]  

  • 12. [Prevention of cardiovascular diseases: Value of CSE inhibitors in the management of lipid metabolism disorders].
    Z Kardiol; 1998 Apr; 87(4 Suppl Stellenwer):1-4. PubMed ID: 9618894
    [No Abstract]   [Full Text] [Related]  

  • 13. [Importance of the clofibrat in the treatment of lipid metabolism disorders].
    Laubinger G
    Med Klin; 1968 Jan; 63(4):139-42. PubMed ID: 5670163
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of dyslipidemias].
    Fonda M; Cattin L; Guarnieri G
    Recenti Prog Med; 2000; 91(7-8):375-8. PubMed ID: 10932924
    [No Abstract]   [Full Text] [Related]  

  • 15. Clinical experimentation of an association of lipotropic drugs.
    Brusasco L; Cavaglià L; Colongo PG
    Panminerva Med; 1968 Mar; 10(3):105-9. PubMed ID: 4172088
    [No Abstract]   [Full Text] [Related]  

  • 16. Clofibrate and androsterone effect on serum lipids.
    Orgain ES; Bogdonoff MD; Cain C
    Arch Intern Med; 1967 Jan; 119(1):80-5. PubMed ID: 6015838
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experience with 110 medium-length therapeutic trials of ethyl chlorophenoxyisobutyrate with or without androsterone in various types of idiopathic hyperlipidemia].
    De Gennes JL; Maunand B; Salmon D; Laudat P; Truffert J
    Rev Atheroscler (Paris); 1966; 8(1):27-52. PubMed ID: 5961027
    [No Abstract]   [Full Text] [Related]  

  • 18. [Dyslipoproteinemia of diabetes: fibrates or statins?].
    Moulin P
    Diabetes Metab; 1999 Sep; 25(3):270-4. PubMed ID: 10499198
    [No Abstract]   [Full Text] [Related]  

  • 19. [The therapeutic use of CPIB in pathological increase of the lipid constituents of the blood].
    Cloarec M; Cottet J; Etienne J; Loeper J
    Sem Ther; 1965 Nov; 41(9):499-500. PubMed ID: 5877602
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of hypocholesteremic agents on the skin.
    Roe DA
    Geriatrics; 1966 Oct; 21(10):174-82. PubMed ID: 5922086
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.